Ironwood Pharmaceuticals, Inc. (IRWD)
5.45
+0.14
(+2.64%)
USD |
NASDAQ |
Jan 22, 14:38
Ironwood Pharmaceuticals Cash from Investing (Quarterly): -0.002M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AbbVie, Inc. | -3.264B |
| Outlook Therapeutics, Inc. | 0.00 |
| Nektar Therapeutics | -94.87M |
| Rigel Pharmaceuticals, Inc. | -33.18M |
| CorMedix, Inc. | -291.32M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 47.58M |
| Free Cash Flow | 67.65M |
| Free Cash Flow Per Share (Quarterly) | 0.2677 |
| Free Cash Flow to Equity (Quarterly) | 48.01M |
| Free Cash Flow to Firm (Quarterly) | 52.55M |
| Free Cash Flow Yield | 7.34% |